Jak Inhibitors in Down Syndrome: Alopecia Areata Resolution and Vitiligo Improvement with Baricitinib
September 2025
in “
Acta Dermato Venereologica
”
TLDR Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.
The study investigates the effects of the JAK inhibitor baricitinib on individuals with Down syndrome, focusing on its impact on alopecia areata and vitiligo. The findings suggest that baricitinib can lead to the resolution of alopecia areata and improvement in vitiligo symptoms in this population. This research highlights the potential of JAK inhibitors as a therapeutic option for managing autoimmune conditions associated with Down syndrome.
